Overview
Cap myopathy (also known as cap disease) is an extremely rare congenital myopathy, a subtype of the broader group of nemaline myopathies, classified under ICD-10 code G71.2. It is named after the characteristic 'cap-like' structures found beneath the sarcolemma (muscle cell membrane) on muscle biopsy. These cap structures consist of disorganized myofibrils and thickened Z-disc material that form peripheral, well-demarcated regions within muscle fibers. The disease primarily affects the skeletal muscular system, leading to progressive or nonprogressive muscle weakness. Clinical features typically include generalized muscle weakness and hypotonia, which may be present from birth or early childhood. Patients often exhibit facial weakness, a long face (elongated facies), high-arched palate, and skeletal abnormalities such as scoliosis, scapular winging, and joint contractures. Respiratory insufficiency is a significant concern and can be life-threatening, particularly in severe neonatal presentations. Dysphagia (difficulty swallowing) and feeding difficulties may also occur. The severity of cap myopathy is highly variable, ranging from mild weakness with near-normal function to severe neonatal forms with respiratory failure. Cap myopathy has been associated with mutations in several genes, including TPM2 (beta-tropomyosin), TPM3 (gamma-tropomyosin), and ACTA1 (skeletal muscle alpha-actin). Most reported cases are sporadic, though autosomal dominant inheritance has been documented in some families. There is currently no cure or disease-specific treatment for cap myopathy. Management is supportive and multidisciplinary, including physical therapy to maintain mobility, respiratory support (including non-invasive ventilation when needed), orthopedic interventions for scoliosis and contractures, and nutritional support for those with feeding difficulties. Regular monitoring of respiratory function is essential.
Also known as:
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
10 eventsDotspace Inc. — NA
OPKO Health, Inc. — PHASE2
Rhode Island Hospital — NA
Shanghai Zhongshan Hospital — NA
Tulavi Therapeutics,Inc.
Second Affiliated Hospital of Nanchang University — NA
Takeda
Alcea — PHASE3
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) — PHASE2
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Cap myopathy.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Cap myopathy at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Cap myopathy.
Community
No community posts yet. Be the first to share your experience with Cap myopathy.
Start the conversation →Latest news about Cap myopathy
Disease timeline:
New recruiting trial: Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy.
A new clinical trial is recruiting patients for Cap myopathy
New recruiting trial: Fufang Congrong Yizhi Capsules (FCYC) of Cognitive Impairment After Intracerebral Hemorrhage
A new clinical trial is recruiting patients for Cap myopathy
New recruiting trial: Clinical Trial With MBK-01, Intestinal Microbiota Capsules, for the Treatment of Patients With Recurrent Diverticulitis
A new clinical trial is recruiting patients for Cap myopathy
New recruiting trial: Clinical Study to Compare Efficacy and Safety of Indinol Forto® 200 mg Capsules and Visanne 2 mg Tablets in Treatment of Endometriosis
A new clinical trial is recruiting patients for Cap myopathy
New recruiting trial: Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder
A new clinical trial is recruiting patients for Cap myopathy
New recruiting trial: Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma
A new clinical trial is recruiting patients for Cap myopathy
New recruiting trial: Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer
A new clinical trial is recruiting patients for Cap myopathy
New recruiting trial: Comparison of Effectiveness of TissuePatchTM in Preventing Postoperative Pancreatic Fistula
A new clinical trial is recruiting patients for Cap myopathy
New recruiting trial: Feasibility of a Minimally Invasive Diagnostic Algorithm in Suspected Crohn's Disease
A new clinical trial is recruiting patients for Cap myopathy
New recruiting trial: PillSense for Suspected Upper Gastrointestinal Bleeding
A new clinical trial is recruiting patients for Cap myopathy
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Cap myopathy
What is Cap myopathy?
Cap myopathy (also known as cap disease) is an extremely rare congenital myopathy, a subtype of the broader group of nemaline myopathies, classified under ICD-10 code G71.2. It is named after the characteristic 'cap-like' structures found beneath the sarcolemma (muscle cell membrane) on muscle biopsy. These cap structures consist of disorganized myofibrils and thickened Z-disc material that form peripheral, well-demarcated regions within muscle fibers. The disease primarily affects the skeletal muscular system, leading to progressive or nonprogressive muscle weakness. Clinical features typica
Which specialists treat Cap myopathy?
25 specialists and care centers treating Cap myopathy are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.